Bérard, C.; Desgranges, S.; Dumas, N.; Novell, A.; Larrat, B.; Hamimed, M.; Taulier, N.; Estève, M.-A.; Correard, F.; Contino-Pépin, C.
Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier Disruption. Pharmaceutics 2022, 14, 1498.
https://doi.org/10.3390/pharmaceutics14071498
AMA Style
Bérard C, Desgranges S, Dumas N, Novell A, Larrat B, Hamimed M, Taulier N, Estève M-A, Correard F, Contino-Pépin C.
Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier Disruption. Pharmaceutics. 2022; 14(7):1498.
https://doi.org/10.3390/pharmaceutics14071498
Chicago/Turabian Style
Bérard, Charlotte, Stéphane Desgranges, Noé Dumas, Anthony Novell, Benoit Larrat, Mourad Hamimed, Nicolas Taulier, Marie-Anne Estève, Florian Correard, and Christiane Contino-Pépin.
2022. "Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier Disruption" Pharmaceutics 14, no. 7: 1498.
https://doi.org/10.3390/pharmaceutics14071498
APA Style
Bérard, C., Desgranges, S., Dumas, N., Novell, A., Larrat, B., Hamimed, M., Taulier, N., Estève, M.-A., Correard, F., & Contino-Pépin, C.
(2022). Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier Disruption. Pharmaceutics, 14(7), 1498.
https://doi.org/10.3390/pharmaceutics14071498